Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2024 Feb 29;14:1343421. doi: 10.3389/fonc.2024.1343421

Corrigendum: Establishment of tumor treating fields combined with mild hyperthermia as novel supporting therapy for pancreatic cancer

Liping Bai 1,, Tobias Pfeifer 1, Wolfgang Gross 1, Carolina De La Torre 2, Shuyang Zhao 3, Li Liu 1, Michael Schaefer 1,, Ingrid Herr 1,*,
PMCID: PMC10938164  PMID: 38487722

Error in Figure 3

Figure 3.

Figure 3

TTField-mediated inhibition of migration is stronger upon combination with hyperthermia. AsPC-1, BxPC-3 and Bx-GEM cells were seeded at a density of 4,000 cells/well in 96-well plates and grown to 90% confluency overnight. The cell layer was scratched with the tip of a 100-μL pipet, followed by treatment of the cells with TTFields at 38.5°C for 24 h. The controls (CO) were incubated at 38.5°C without exposure to TTFields. The closure of the wounded region was evaluated by microscopy at 0, 12 and 24 h after scratching. The gap width was measured using ImageJ. Representative images are shown on the left, and the means are shown in bar graphs on the right. The data are presented as the means ± SD. *P < 0.05, **P < 0.01.

In the original article, there was a duplicated, representative image in Figure 3 as published. The representative image of “AsPC-1/CO/12h” was unintentionally swapped. The revised and correct Figure appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES